NWBO
Price
$0.25
Change
-$0.01 (-3.85%)
Updated
Sep 5 closing price
Capitalization
374.47M
VRTX
Price
$396.12
Change
-$0.81 (-0.20%)
Updated
Sep 5 closing price
Capitalization
101.56B
51 days until earnings call
Interact to see
Advertisement

NWBO vs VRTX

Header iconNWBO vs VRTX Comparison
Open Charts NWBO vs VRTXBanner chart's image
Northwest Biotherapeutics
Price$0.25
Change-$0.01 (-3.85%)
Volume$4.86M
Capitalization374.47M
Vertex Pharmaceuticals
Price$396.12
Change-$0.81 (-0.20%)
Volume$1.17M
Capitalization101.56B
NWBO vs VRTX Comparison Chart in %
Loading...
NWBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NWBO vs. VRTX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWBO is a Hold and VRTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (NWBO: $0.25 vs. VRTX: $396.12)
Brand notoriety: NWBO and VRTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NWBO: 144% vs. VRTX: 68%
Market capitalization -- NWBO: $374.47M vs. VRTX: $101.56B
NWBO [@Biotechnology] is valued at $374.47M. VRTX’s [@Biotechnology] market capitalization is $101.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NWBO’s FA Score shows that 0 FA rating(s) are green whileVRTX’s FA Score has 0 green FA rating(s).

  • NWBO’s FA Score: 0 green, 5 red.
  • VRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VRTX is a better buy in the long-term than NWBO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NWBO’s TA Score shows that 6 TA indicator(s) are bullish while VRTX’s TA Score has 3 bullish TA indicator(s).

  • NWBO’s TA Score: 6 bullish, 4 bearish.
  • VRTX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, NWBO is a better buy in the short-term than VRTX.

Price Growth

NWBO (@Biotechnology) experienced а -16.07% price change this week, while VRTX (@Biotechnology) price change was +1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

VRTX is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRTX($102B) has a higher market cap than NWBO($374M). VRTX YTD gains are higher at: -1.634 vs. NWBO (-8.055). VRTX has higher annual earnings (EBITDA): 4.59B vs. NWBO (-72.28M). VRTX has more cash in the bank: 6.38B vs. NWBO (4.32M). NWBO has less debt than VRTX: NWBO (69.8M) vs VRTX (1.53B). VRTX has higher revenues than NWBO: VRTX (11.4B) vs NWBO (1.09M).
NWBOVRTXNWBO / VRTX
Capitalization374M102B0%
EBITDA-72.28M4.59B-2%
Gain YTD-8.055-1.634493%
P/E RatioN/A28.17-
Revenue1.09M11.4B0%
Total Cash4.32M6.38B0%
Total Debt69.8M1.53B5%
FUNDAMENTALS RATINGS
NWBO vs VRTX: Fundamental Ratings
NWBO
VRTX
OUTLOOK RATING
1..100
5081
VALUATION
overvalued / fair valued / undervalued
1..100
46
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
10051
SMR RATING
1..100
10042
PRICE GROWTH RATING
1..100
6163
P/E GROWTH RATING
1..100
10071
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NWBO's Valuation (46) in the Biotechnology industry is in the same range as VRTX (72). This means that NWBO’s stock grew similarly to VRTX’s over the last 12 months.

VRTX's Profit vs Risk Rating (51) in the Biotechnology industry is somewhat better than the same rating for NWBO (100). This means that VRTX’s stock grew somewhat faster than NWBO’s over the last 12 months.

VRTX's SMR Rating (42) in the Biotechnology industry is somewhat better than the same rating for NWBO (100). This means that VRTX’s stock grew somewhat faster than NWBO’s over the last 12 months.

NWBO's Price Growth Rating (61) in the Biotechnology industry is in the same range as VRTX (63). This means that NWBO’s stock grew similarly to VRTX’s over the last 12 months.

VRTX's P/E Growth Rating (71) in the Biotechnology industry is in the same range as NWBO (100). This means that VRTX’s stock grew similarly to NWBO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NWBOVRTX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
56%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
49%
MACD
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 11 days ago
60%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 13 days ago
41%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
48%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
38%
View a ticker or compare two or three
Interact to see
Advertisement
NWBO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
RLC.X1.3055550.065563
+5.29%
iExec RLC cryptocurrency
SGDJ61.261.70
+2.85%
Sprott Junior Gold Miners ETF
TEK29.220.20
+0.68%
iShares Technology Opports Act ETF
AHLT22.78-0.08
-0.33%
American Beacon AHL Trend ETF
NEO.X6.465648-0.044595
-0.69%
Neo cryptocurrency

NWBO and

Correlation & Price change

A.I.dvisor tells us that NWBO and CCCC have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NWBO and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NWBO
1D Price
Change %
NWBO100%
-2.84%
CCCC - NWBO
24%
Poorly correlated
+1.87%
CBUS - NWBO
23%
Poorly correlated
+1.59%
XERS - NWBO
23%
Poorly correlated
-0.51%
GLUE - NWBO
22%
Poorly correlated
+0.61%
VRTX - NWBO
21%
Poorly correlated
-0.20%
More

VRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRTX has been loosely correlated with NEVPF. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VRTX jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRTX
1D Price
Change %
VRTX100%
-0.20%
NEVPF - VRTX
47%
Loosely correlated
N/A
SNDX - VRTX
41%
Loosely correlated
+5.25%
REGN - VRTX
40%
Loosely correlated
+1.09%
IDYA - VRTX
36%
Loosely correlated
+5.15%
RGNX - VRTX
34%
Loosely correlated
+3.08%
More